Zhejiang Huamei Holding Co.Ltd(000607) : Zhejiang Huamei Holding Co.Ltd(000607) short form equity change report

Zhejiang Huamei Holding Co.Ltd(000607)

Short form equity change report

Name of listed company: Zhejiang Huamei Holding Co.Ltd(000607)

Listing place: Shenzhen Stock Exchange

Stock abbreviation: Zhejiang Huamei Holding Co.Ltd(000607)

Stock Code: 000607

Information disclosure obligor 1: address and mailing address of Huali Group Co., Ltd.: No. 181, Wuchang Avenue, Yuhang District, Hangzhou information disclosure obligor 2: address and mailing address of Huali Pharmaceutical Group Co., Ltd.: No. 181, Wuchang Avenue, Yuhang District, Hangzhou information disclosure obligor 3: address and mailing address of Zhejiang Huali Investment Management Co., Ltd.: Zhoushan port comprehensive free trade zone Room 303-2103, enterprise service center

Nature of share change: share reduction

Date of signature: February 17, 2022

Statement of information disclosure obligor

(I) the information disclosure obligor prepares this equity change report in accordance with the securities law of the people's Republic of China, the measures for the administration of the acquisition of listed companies, the standards for the content and format of information disclosure by companies that publicly issue securities No. 15 - equity change report and other relevant laws and regulations.

(II) the information disclosure obligor has obtained necessary authorization and approval for signing this report, and its performance does not violate or conflict with any provision in the articles of association or internal rules of the information disclosure obligor.

(III) in accordance with the provisions of the securities law of the people's Republic of China and the measures for the administration of the acquisition of listed companies, this report has fully disclosed the changes in Zhejiang Huamei Holding Co.Ltd(000607) shares held by the information disclosure obligor.

As of the signing date of this report, except for the shareholding information disclosed in this report, the information disclosure obligor has not increased or reduced its shares in Zhejiang Huamei Holding Co.Ltd(000607) by any other means.

(IV) this equity change is based on the data stated in this report. The information disclosure obligor has not entrusted or authorized any other person to provide information not listed in this report and make any explanation or explanation to this report.

(V) the information disclosure obligor promises that there are no false records, misleading statements or major omissions in this report, and will bear individual and joint legal liabilities for its authenticity, accuracy and completeness.

catalogue

The disclosure obligor declares that 2 catalog 3 interpretation Section 1 Introduction to information disclosure obligors five

1、 Information disclosure obligor five

2、 Basic information of directors and main principals of information disclosure obligors (III) the shares in which the information disclosure obligor has interests in other domestic and overseas listed companies reach or exceed the number of shares that the company has

5% of the shares issued eight

Section II purpose of equity change of information disclosure obligor nine

1、 Purpose of this equity change 9 2. Whether the information disclosure obligor intends to continue to increase or decrease its interests in the listed company in the next 12 months

Shares of Section III change of rights and interests of information disclosure obligors ten

1、 Information disclosure obligors holding shares of listed companies ten

2、 Changes in equity this time ten

2、 After this equity change, the information disclosure obligor holds shares of the listed company thirteen

3、 Restrictions on the rights of shares of listed companies held by information disclosure obligors Section IV trading of shares of Listed Companies in the first six months Section V other major matters Section VI documents for future reference seventeen

1、 Documents for future reference seventeen

2、 Location of documents for future reference 17 schedule nineteen

interpretation

Unless otherwise stated, the following words and expressions in this simplified equity change report have the following meanings:

Zhejiang Huamei Holding Co.Ltd(000607) / listed company refers to Zhejiang Huamei Holding Co.Ltd(000607)

Information disclosure obligor / Huali group refers to Huali Group Co., Ltd

Information disclosure obligors and persons acting in concert through this equity change in Shenzhen refer to the cumulative reduction of Zhejiang Huamei Holding Co.Ltd(000607) shares by the stock exchange through centralized bidding trading and block trading

Huali Pharmaceutical Group Co., Ltd

Acting in concert: Zhejiang Huali Investment Management Co., Ltd

Hua'an future assets - Bank Of Ningbo Co.Ltd(002142) - Huali Group Co., Ltd

Huali Pharmaceutical Group Co., Ltd

Zhejiang Huali Investment Management Co., Ltd

Hua'an asset management plan Hua'an future assets - Bank Of Ningbo Co.Ltd(002142) - Huali Group Co., Ltd

This report / this report refers to the Zhejiang Huamei Holding Co.Ltd(000607) simplified equity change report

Exchange and Shenzhen Stock Exchange refer to Shenzhen Stock Exchange

Yuan means RMB yuan

Section I Introduction to information disclosure obligors

1、 Information disclosure obligor (I) information disclosure obligor I:

Company name: Huali Group Co., Ltd

Unified social credit code 913300007042069982

Enterprise type Co., Ltd. (unlisted)

The registered capital is 303.38 million yuan

Legal representative: Wang Siyang

Date of establishment: June 6, 1999

Long term operation

Registered address: No. 181, Wuchang Avenue, Yuhang District, Hangzhou

The major shareholder Zhejiang Licheng Industrial Co., Ltd. holds 81.67% and Wang Licheng holds 5.82%

Business of hazardous chemicals (see the business license of hazardous chemicals and the business Filing Certificate of non pharmaceutical precursor chemicals for details), and carry out the business of foreign contracted projects (see the qualification certificate of foreign contracted projects for details).

Industrial investment, asset management, China and international trade (those involving licensed operation and special approval shall be operated with valid certificates and license documents), food business scope (operated with licenses), technical services, management consulting, equipment leasing, primary edible agricultural products, aquatic products, coal (without storage), coke Sales of fuel oil (excluding refined oil), power equipment, precious metals and gold jewelry, development and technical consultation of power generation and transmission and transformation technology, and production and manufacturing of instruments and meters. (for projects subject to approval according to law, business activities can be carried out only after approval by relevant departments)

(II) information disclosure obligations:

Company name: Huali Pharmaceutical Group Co., Ltd

Unified social credit code 91330000142918204l

Enterprise type: limited liability company (sole proprietorship of legal person invested or controlled by non natural person)

The registered capital is 370 million yuan

Legal representative: Xu Liang

Date of establishment: June 21, 1996

Long term operation

Registered address: No. 181, Wuchang Avenue, Yuhang District, Hangzhou

The major shareholder Huali Group Co., Ltd. holds 100%

Wholesale of drugs; Import and export of drugs; Commissioned production of drugs; Food sales; Medical services; Disinfection equipment sales; The import and export of goods under the administration of state-owned trade (for items that must be approved according to law, business activities can be carried out only after being approved by relevant departments, and the specific business items shall be subject to the approval results). General items: food sales (only pre packaged food); Sales of health food (prepackaged); Sales of class II medical devices; Sales of disinfectants (excluding hazardous chemicals); Daily necessities sales business scope; Sales of personal hygiene products; Sales of sanitary supplies and disposable medical supplies; Sales of chemical products (excluding licensed chemical products); Sales of synthetic materials; Sales of metal materials; Sale of gold and silver products; Sales of petroleum products (excluding hazardous chemicals); Health consulting services (excluding diagnosis and treatment services); Safety technical training for special operation personnel; Sales of clothing accessories (except for the items that must be approved according to law, carry out business activities independently according to law with the business license).

(III) three information disclosure obligors:

Company name: Zhejiang Huali Investment Management Co., Ltd

Unified social credit code 91330901313699684l

Investment of unincorporated or limited liability company

Registered capital: 50 million yuan

Legal representative: Pei Rong

Date of establishment: November 3, 2014

Long term operation

Registered address: room 303-2103, enterprise service center, Zhoushan port comprehensive free trade zone

The major shareholder Huali Group Co., Ltd. holds 100%

Business scope: investment management, equity investment and project investment.

(IV) equity relationship and control relationship between information disclosure obligors

Huali Group Co., Ltd., Huali Pharmaceutical Group Co., Ltd., Zhejiang Huali Investment Management Co., Ltd. and Hua'an future assets - Bank Of Ningbo Co.Ltd(002142) - Huali Group Co., Ltd. are the persons acting in concert. Holley Group

Hold 100% equity of Huali pharmaceutical and 100% equity of Huali investment respectively. Huaan asset management plan is the stock of Huali group

An asset management plan established by a limited company as a single asset client.

Wang Licheng (holding Huali group)

87.49%)

100%

Zhejiang Licheng Industrial Co., Ltd

5.82%

81.67%

Huali Group Co., Ltd

100% asset consignor

Huali Pharmaceutical Group Co., Ltd. Zhejiang Huali Investment Management Co., Ltd. Hua'an future asset management Co., Ltd. II. Basic information of directors and main principals of information disclosure obligors

(I) as of the issuance date of this report, Huali group, the obligor of information disclosure, has 5 directors in total

The situation is as follows:

Serial number name gender position nationality long-term residence in other countries

Right of abode in home or region

1 Wang Licheng, male, chairman, Hangzhou, China no

2 Wang Siyang, male, General Manager / Director, Hangzhou, China no

3 Pei Rong, female director, Hangzhou, China no

- Advertisment -